The Pentagon's Software Pivot
The U.S. Army's $10 billion enterprise agreement with Palantir signals a major shift in defense procurement toward consolidated software contracts. This new model creates opportunities for other large technology firms capable of providing streamlined, large-scale IT and AI solutions to the military.
Your Basket's Financial Footprint
Market capitalisation breakdown for the basket 'The Pentagon's Software Pivot'.
- Large-cap concentration generally implies greater stability, lower volatility and closer alignment with broad-market performance.
- Use this basket as a core, long-term holding rather than for speculative, high-growth trading.
- Expect steady, long-term appreciation; rapid, explosive gains are unlikely.
PLTR: $430.42B
MSFT: $3.85T
ORCL: $784.40B
- Other
About This Group of Stocks
Our Expert Thinking
The U.S. Army's $10 billion enterprise agreement with Palantir represents a fundamental shift in defense procurement. Instead of managing dozens of separate contracts, the military is moving toward consolidated, large-scale software solutions. This creates significant opportunities for technology companies that can deliver comprehensive, enterprise-level systems.
What You Need to Know
This group focuses on established and emerging defense technology contractors positioned to benefit from the Pentagon's new procurement model. These companies specialise in enterprise IT, cloud infrastructure, advanced analytics, and cybersecurity - all critical capabilities for modern military operations.
Why These Stocks
These stocks were handpicked based on their ability to provide streamlined, large-scale technology solutions to the military. Each company has the technical expertise and operational scale needed to compete for future enterprise-level agreements as the Department of Defense continues modernising its digital capabilities.
Why You'll Want to Watch These Stocks
Pentagon's New Playbook
The military's shift from fragmented contracts to massive enterprise deals creates a completely new competitive landscape. Companies that can scale and deliver comprehensive solutions stand to win big.
Billion-Dollar Opportunities
With the Army's $10 billion Palantir deal setting the precedent, similar mega-contracts could be on the horizon. The potential for massive revenue streams has never been clearer.
First-Mover Advantage
As the Pentagon modernises its digital infrastructure, early winners in this space could establish dominant positions that last for decades. The transformation is just beginning.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Railroad Investment: Beyond the $85 Billion Merger
Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.
Oracle TikTok Deal May Boost Stocks in 2025
TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.
Pharma Reshoring Explained | Manufacturing Investment
Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.